InspireMD (NSPR) Misses Q2 EPS by 3c

InspireMD (NYSE: NSPR) reported Q2 EPS of ($0.08), $0.03 worse than the analyst estimate of ($0.05). Revenue for the quarter came in at $477 thousand versus the consensus estimate of $850 thousand.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Meta capex to surge in 2027, neocloud fears ’erroneous’ - SemiAnalysis
• Morgan Stanley Resumes Urban Outfitters, Inc. (URBN) at Overweight
• Intercontinental Exchange (ICE) PT Lowered to $208 at Raymond James, 'we view the risk/reward as attractive'